Real life efficacy and tolerability of Tenofovir Alafenamide Fumarate in patients with hepatitis-B virus-related cirrhosis

被引：0
|
作者：
Yapali, Suna [1 ]
Gokcan, Hale [2 ]
Durak, Serdar [3 ]
Ellik, Zeynep Melekoglu [2 ]
Guzelbulut, Fatih [4 ]
Vatansever, Sezgin [5 ]
Ari, Derya [6 ]
Mehdiyev, Shahin [7 ]
Adanir, Haydar [8 ]
Koc, Elif Sitre
Gunduz, Feyza [7 ]
Arslan, Mehmet [3 ]
Ozdil, Kamil [9 ]
Dincer, Dinc [8 ]
Idilman, Ramazan [2 ]
机构：
[1] Acibadem Univ, Istanbul, Turkey
[2] Ankara Univ, Med Sch, Ankara, Turkey
[3] KTU Fac Med, Trabzon, Turkey
[4] SBU Haydarpasa Numune Egitim & Arastirma Hastane, Istanbul, Turkey
[5] Katip Celebi Univ, Izmir, Turkey
[6] Ankara Sehir Hastanesi, Ankara, Turkey
[7] Marmara Univ, Res & Educ Hosp, Istanbul, Turkey
[8] Akdeniz Univ, Antalya, Turkey
[9] Saglik Bilimleri Univ, Umraniye Egitim & Arastirma Hastanesi, Istanbul, Turkey
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT421
引用
收藏
页码：S864 / S864
页数：1
相关论文
共 50 条
  • [31] 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
    Agarwal, Kosh
    Brunetto, Maurizia
    Seto, Wai Kay
    Lim, Young-Suk
    Fung, Scott
    Marcellin, Patrick
    Ahn, Sang Hoon
    Izumi, Namiki
    Chuang, Wan-Long
    Bae, Ho
    Sharma, Manoj
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Celen, Mustafa Kemal
    Furusyo, Norihiro
    Shalimar, Dr
    Yoon, Ki Tae
    Huy Trinh
    Flaherty, John F.
    Gaggar, Anuj
    Lau, Audrey H.
    Cathcart, Andrea L.
    Lin, Lanjia
    Bhardwaj, Neeru
    Suri, Vithika
    Subramanian, G. Mani
    Gane, Edward J.
    Buti, Maria
    Chan, Henry L. Y.
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 672 - 681
  • [32] Efficacy and safety of tenofovir alafenamide fumarate in nucleoside analogue treatment-naive patients with chronic hepatitis B
    Chen, Peng
    Wei, Wei
    Jin, Li
    Kuai, Wentao
    Li, Fei
    Liu, Huan
    Jiang, Bei
    Zhu, Yu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 22 (05)
  • [33] Early antiviral efficacy of tenofovir alafenamide fumarate in the initial treatment of chronic hepatitis B patients with normal ALT
    Xing, Huichun
    Chi, Xin
    Sun, Xiu
    Cheng, Danying
    Liu, Shunai
    JOURNAL OF HEPATOLOGY, 2022, 77 : S852 - S852
  • [34] Long-term efficacy and safety of tenofovir alafenamide, tenofovir disoproxil fumarate, and entecavir in treating hepatitis B virus-related acute-on-chronic liver failure: A 144-week data analysis
    Zhang, Yeqiong
    Xu, Wenxiong
    Deng, Zhexuan
    Wang, Lu
    Zheng, Xingrong
    Zhu, Xiang
    Li, Xuejun
    Li, Jianguo
    Shu, Xin
    Lai, Jing
    Peng, Liang
    Xie, Chan
    LIVER RESEARCH, 2024, 8 (04) : 295 - 303
  • [35] Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
    Cheng, Chih-Hsien
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    ANNALS OF TRANSPLANTATION, 2023, 28
  • [36] Efficacy and safety of tenofovir alafenamide fumarate for preventing mother to child transmission of hepatitis B virus: a national cohort study
    Ding, Yang
    Cao, Lihua
    Zhu, Liying
    Huang, Yan
    Lin, Chaoshuang
    Wang, Yuming
    Liu, Yingxia
    Sheng, Qiuju
    Wang, Shouyun
    Fan, Jian
    Chen, Ruochan
    Gan, Weiqiang
    Chen, Bryan
    Pan, Calvin Q.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1377 - 1386
  • [37] Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Lim, Young-Suk
    Chan, Henry L. Y.
    Ahn, Sang Hoon
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar, Maurizia
    Brunetto, Maurizia
    Hui, Aric Josun
    Chang, Ting-Tsung
    Lim, Seng Gee
    Abramov, Frida
    Flaherty, John F.
    Wang, Hongyuan
    Yee, Leland J.
    Kao, Jia-Horng
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    JHEP REPORTS, 2023, 5 (10)
  • [38] Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study
    Alghamdi, Abdullah S.
    Alothmani, Hammad S.
    Mogharbel, Mohammed
    Albiladi, Hazeez
    Babatin, Mohamed
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [39] Twenty Eight Day Safety and Efficacy of Tenofovir Alafenamide (TAF) Fumarate in Chronic Hepatitis B (CHB) Patients
    Agarwal, Kosh
    Fung, Scott K.
    Nguyen, Tuan T.
    Cheng, Wendy
    Sicard, Eric
    Ryder, Stephen D.
    Flaherty, John F.
    Lawson, Eileen
    Zhao, Sally
    Subramanian, Mani
    McHutchison, John G.
    Gane, Edward J.
    Foster, Graham R.
    HEPATOLOGY, 2013, 58 : 675A - 675A
  • [40] Long-term antiviral efficacy of entecavir in patients with hepatitis B virus-related cirrhosis
    Xu, Yan
    Zhou, Changyu
    Zhang, Yonggui
    Ji, Shangwei
    Zhao, Ping
    Guo, Honghua
    Jiao, Jian
    Li, Yan
    Wang, Jiangbin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 394 - 394
12345